Collectively, these evidence suggest that midkine may play a key role in the pathogenesis of autoimmune diseases including SLE, inhibiting midkine therefore might be useful for attenuating inflammation-related symptoms in these diseases. The gene discussed is MDK; the disease is autoimmune disease.